TBFA
VRTX icon

Three Bearings Fiduciary Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Three Bearings Fiduciary Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48K Hold
5
– – ﹤0.01% 200
2026
Q1 		$2.23K Hold
5
– – ﹤0.01% 208
2025
Q4 		$2.35K Buy
+5
New +$2.15K ﹤0.01% 217

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Three Bearings Fiduciary Advisors's VRTX Position: Q2 2026 in Review

Three Bearings Fiduciary Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 5 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #200.

Three Bearings Fiduciary Advisors first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. 1,014 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Three Bearings Fiduciary Advisors held 5 shares of Vertex Pharmaceuticals worth $2.48K as of Q2 2026.
  • Three Bearings Fiduciary Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Three Bearings Fiduciary Advisors's portfolio in Q2 2026, its #200 holding.
  • Three Bearings Fiduciary Advisors first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 1,014 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Three Bearings Fiduciary Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.